An Interpretable and Predictive Connectivity-Based Neural Signature for Chronic Cannabis Use.

Biomarker Cannabis Craving Interpretability Machine learning Neuroimaging Substance use

Journal

Biological psychiatry. Cognitive neuroscience and neuroimaging
ISSN: 2451-9030
Titre abrégé: Biol Psychiatry Cogn Neurosci Neuroimaging
Pays: United States
ID NLM: 101671285

Informations de publication

Date de publication:
03 2023
Historique:
received: 08 12 2021
revised: 10 04 2022
accepted: 27 04 2022
pubmed: 7 6 2022
medline: 11 3 2023
entrez: 6 6 2022
Statut: ppublish

Résumé

Cannabis is one of the most widely used substances in the world, with usage trending upward in recent years. However, although the psychiatric burden associated with maladaptive cannabis use has been well established, reliable and interpretable biomarkers associated with chronic use remain elusive. In this study, we combine large-scale functional magnetic resonance imaging with machine learning and network analysis and develop an interpretable decoding model that offers both accurate prediction and novel insights into chronic cannabis use. Chronic cannabis users (n = 166) and nonusing healthy control subjects (n = 124) completed a cue-elicited craving task during functional magnetic resonance imaging. Linear machine learning methods were used to classify individuals into chronic users and nonusers based on whole-brain functional connectivity. Network analysis was used to identify the most predictive regions and communities. We obtained high (∼80% out-of-sample) accuracy across 4 different classification models, demonstrating that task-evoked connectivity can successfully differentiate chronic cannabis users from nonusers. We also identified key predictive regions implicating motor, sensory, attention, and craving-related areas, as well as a core set of brain networks that contributed to successful classification. The most predictive networks also strongly correlated with cannabis craving within the chronic user group. This novel approach produced a neural signature of chronic cannabis use that is both accurate in terms of out-of-sample prediction and interpretable in terms of predictive networks and their relation to cannabis craving.

Sections du résumé

BACKGROUND
Cannabis is one of the most widely used substances in the world, with usage trending upward in recent years. However, although the psychiatric burden associated with maladaptive cannabis use has been well established, reliable and interpretable biomarkers associated with chronic use remain elusive. In this study, we combine large-scale functional magnetic resonance imaging with machine learning and network analysis and develop an interpretable decoding model that offers both accurate prediction and novel insights into chronic cannabis use.
METHODS
Chronic cannabis users (n = 166) and nonusing healthy control subjects (n = 124) completed a cue-elicited craving task during functional magnetic resonance imaging. Linear machine learning methods were used to classify individuals into chronic users and nonusers based on whole-brain functional connectivity. Network analysis was used to identify the most predictive regions and communities.
RESULTS
We obtained high (∼80% out-of-sample) accuracy across 4 different classification models, demonstrating that task-evoked connectivity can successfully differentiate chronic cannabis users from nonusers. We also identified key predictive regions implicating motor, sensory, attention, and craving-related areas, as well as a core set of brain networks that contributed to successful classification. The most predictive networks also strongly correlated with cannabis craving within the chronic user group.
CONCLUSIONS
This novel approach produced a neural signature of chronic cannabis use that is both accurate in terms of out-of-sample prediction and interpretable in terms of predictive networks and their relation to cannabis craving.

Identifiants

pubmed: 35659965
pii: S2451-9022(22)00126-4
doi: 10.1016/j.bpsc.2022.04.009
pmc: PMC9708942
mid: NIHMS1829709
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-330

Subventions

Organisme : NIDA NIH HHS
ID : R21 DA049243
Pays : United States
Organisme : NIH HHS
ID : S10 OD026880
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH118418
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA043695
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007280
Pays : United States
Organisme : NIMH NIH HHS
ID : F31 MH123123
Pays : United States

Informations de copyright

Copyright © 2022 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Auteurs

Kaustubh R Kulkarni (KR)

Center for Computational Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.

Matthew Schafer (M)

Center for Computational Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.

Laura A Berner (LA)

Center for Computational Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.

Vincenzo G Fiore (VG)

Center for Computational Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.

Matt Heflin (M)

Center for Computational Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.

Kent Hutchison (K)

Institute for Cognitive Science, University of Colorado, Boulder, Colorado.

Vince Calhoun (V)

Tri-institutional Center for Translational Research in Neuroimaging and Data Science, Georgia State University, Georgia Institute of Technology, Emory University, Atlanta, Georgia.

Francesca Filbey (F)

Center for BrainHealth, School of Behavioral and Brain Sciences, University of Texas at Dallas, Dallas, Texas.

Gaurav Pandey (G)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.

Daniela Schiller (D)

Center for Computational Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.

Xiaosi Gu (X)

Center for Computational Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: xiaosi.gu@mssm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH